Cite
HARVARD Citation
Cea, M. et al. (2016). Exploiting tumor vulnerabilities: NAD+-depleting agents combined with anti-tumor drugs as innovative strategy to treat hematological malignancies. Expert review of anticancer therapy. 16 (9), pp. 897-898. [Online].